IDEXX LABORATORIES INC /DE IDXX Balance Sheet

Idexx laboratories inc /de (IDXX)

Balance Sheet / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Dec'09
ASSETS
Current Assets:
Cash and cash equivalents
81	90	103	110	116	123	146	174	159	187	169	165	160	154	150	141	132	128	141	163	182	322	292	305	286	279	264	251	228	223	221	201	185	183	181	159	153	156	133	117	106
Marketable securities
-	-	-	-	-	-	0	0	-	284	285	256	239	236	241	229	217	213	208	180	139	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts receivable, net
299	269	268	286	281	248	264	265	259	234	228	240	225	204	204	212	212	188	190	199	196	152	160	168	179	158	151	159	158	138	141	147	160	141	134	149	137	120	120	127	115
Inventory, Net
211	195	204	196	189	173	179	176	179	164	176	169	172	158	168	175	183	188	192	184	173	160	156	145	141	133	145	140	148	140	147	143	141	133	137	133	127	127	131	122	110
Deferred income tax assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	39	36	37	36	37	33	33	32	33	27	26	25	27	25	25	23	25	27	26	25	26	24	23	25
Other Assets, Current
128	124	126	118	110	108	113	123	103	101	83	85	80	91	63	62	62	62	63	67	81	86	60	48	43	48	35	37	33	38	35	37	33	40	29	24	21	29	19	19	18
Total current assets
721	679	703	712	697	654	704	739	701	971	942	918	878	845	828	821	809	821	833	833	808	759	702	701	683	652	625	614	594	569	570	555	544	524	510	493	465	460	429	410	376
Long-Term Assets:
Property and equipment, net
546	533	496	469	449	437	409	394	384	379	367	364	361	357	349	347	343	333	320	326	309	303	291	286	282	281	274	266	253	245	231	220	216	216	213	210	202	201	200	196	199
Operating lease right-of-use assets
78	80	78	81	80	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill
233	239	212	215	214	214	216	195	201	199	199	196	180	178	180	180	181	178	180	179	176	184	176	181	180	180	180	171	172	174	174	170	175	172	150	154	152	149	148	143	148
Intangible assets, net
57	58	35	37	39	41	42	39	41	43	45	46	45	46	47	49	53	55	58	57	59	65	59	55	57	58	61	58	61	62	63	64	68	69	50	53	54	55	57	57	63
Other long-term assets
248	240	224	207	199	189	171	151	140	118	114	110	105	103	94	90	91	85	84	81	75	71	60	57	59	57	53	53	51	51	52	55	55	47	43	39	34	29	25	25	19
Total long-term assets
1,164	1,152	1,048	1,011	983	883	840	780	767	741	726	718	693	685	672	668	669	653	643	644	622	624	588	581	579	577	570	549	538	534	522	512	516	506	458	457	444	436	432	423	432
TOTAL ASSETS
1,886	1,832	1,751	1,724	1,680	1,537	1,544	1,520	1,469	1,713	1,669	1,637	1,572	1,530	1,500	1,489	1,478	1,474	1,477	1,477	1,431	1,384	1,290	1,283	1,262	1,230	1,195	1,164	1,132	1,103	1,093	1,067	1,061	1,030	969	950	909	897	862	833	808
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current Liabilities:
Accounts payable
74	72	75	67	70	69	65	68	70	66	60	58	62	60	44	50	52	52	53	58	44	44	58	41	42	29	38	37	38	35	31	29	40	36	31	29	23	22	25	23	19
Accrued liabilities
247	322	278	256	229	260	238	228	210	253	220	210	174	236	202	188	178	205	203	190	177	195	167	147	134	148	134	123	118	137	134	128	126	141	136	121	107	118	108	99	104
Line of credit
486	288	229	251	346	398	414	437	407	655	686	704	671	611	488	558	622	573	542	498	549	549	375	384	315	277	397	367	260	212	232	244	254	243	154	132	126	128	125	133	118
Current portion of deferred revenue
38	41	42	43	43	41	41	40	40	29	29	28	28	27	26	25	25	25	24	28	31	31	29	27	23	21	22	21	21	20	16	16	15	15	13	12	14	13	10	13	12
Current portion of long-term debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0
Total current liabilities
846	725	626	618	689	770	759	774	728	1,004	996	1,001	936	934	760	822	878	856	824	775	803	820	630	600	517	478	592	551	439	406	415	419	437	436	336	298	272	285	270	271	256
Long-Term Liabilities:
Deferred income tax liabilities
38	33	33	32	32	29	39	35	27	25	33	37	39	39	20	16	15	49	36	39	40	41	27	28	31	33	22	22	22	23	20	21	22	23	20	21	20	18	20	17	18
Long-term debt
697	698	696	700	699	601	602	603	609	606	604	600	594	593	599	597	600	597	599	598	500	350	350	150	150	150	0	0	1	1	1	2	2	2	2	2	3	3	3	3	4
Long-term deferred revenue, net of current portion
49	48	48	52	55	60	62	65	68	35	34	34	33	33	30	30	27	27	25	23	22	21	21	20	19	18	15	13	12	12	14	13	12	10	8	6	4	4	8	4	3
Operating Lease, Liability, Noncurrent
65	67	66	69	68	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other long-term liabilities
81	81	77	79	82	84	81	83	84	95	49	49	42	38	34	30	30	28	29	31	31	32	31	30	31	31	28	25	24	23	22	21	20	17	15	12	12	11	12	11	11
Total long-term liabilities
931	929	922	933	939	776	786	787	789	762	721	721	709	704	685	674	673	702	691	693	593	445	430	229	232	233	67	62	61	61	59	58	56	54	46	43	40	37	44	38	37
Total liabilities
1,778	1,654	1,548	1,552	1,629	1,546	1,545	1,561	1,518	1,767	1,717	1,723	1,646	1,638	1,445	1,497	1,552	1,558	1,516	1,468	1,396	1,266	1,061	830	750	712	660	614	501	467	475	477	494	491	383	341	312	322	315	309	293
Commitments and Contingencies (Note 16)
-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	-	-	-
Stockholders’ Equity:
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 105,914 shares in 2020 and 105,711 shares in 2019; Outstanding: 84,929 shares in 2020 and 85,471 shares in 2019
10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	9	9	9	9	9	9	9	9	9	9	9
Additional paid-in capital
1,230	1,213	1,189	1,170	1,155	1,138	1,128	1,109	1,094	1,073	1,060	1,046	1,030	1,011	994	972	952	940	931	921	912	888	866	856	847	825	798	787	779	757	742	726	716	702	694	680	665	641	626	613	580
Deferred stock units: Outstanding: 144 units in 2020 and 143 units in 2019
4	4	4	4	4	4	4	4	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	4	4	4	4	4	4	4	4	4	4	4	4	4
Retained earnings
1,705	1,595	1,505	1,396	1,270	1,167	1,082	989	880	803	765	694	609	540	488	431	364	318	274	231	1,721	1,675	1,649	1,597	1,539	1,493	1,450	1,404	1,350	1,305	1,262	1,219	1,168	1,127	1,089	1,050	1,002	965	929	894	824
Accumulated other comprehensive loss
-55	-46	-45	-40	-40	-41	-42	-42	-34	-36	-34	-38	-38	-43	-35	-35	-37	-42	-37	-22	-24	-8	1	15	14	13	15	10	11	15	14	8	19	15	18	26	19	13	11	2	10
Treasury stock, at cost: 20,985 shares in 2020 and 20,240 shares in 2019
2,788	2,600	2,461	2,370	2,350	2,288	2,185	2,111	2,005	1,911	1,856	1,805	1,691	1,633	1,408	1,392	1,369	1,316	1,222	1,137	2,591	2,453	2,303	2,031	1,904	1,829	1,744	1,667	1,525	1,457	1,415	1,379	1,352	1,320	1,230	1,163	1,104	1,060	1,034	1,001	914
Total IDEXX Laboratories, Inc. stockholders’ equity
107	177	202	171	51	-9	-1	-41	-49	-54	-48	-86	-74	-108	54	-8	-73	-84	-38	8	34	117	229	452	512	518	534	549	631	636	617	589	566	539	585	608	596	574	546	524	514
Noncontrolling interest
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
108	177	202	171	51	-9	-1	-40	-48	-53	-48	-86	-73	-108	54	-8	-73	-83	-38	8	34	117	229	452	512	518	534	549	631	636	617	589	566	539	585	608	596	574	546	524	514
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
1,886	1,832	1,751	1,724	1,680	1,537	1,544	1,520	1,469	1,713	1,669	1,637	1,572	1,530	1,500	1,489	1,478	1,474	1,477	1,477	1,431	1,384	1,290	1,283	1,262	1,230	1,195	1,164	1,132	1,103	1,093	1,067	1,061	1,030	969	950	909	897	862	833	808